Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294.SZ)
CNY 35.49
(0.31%)
CNY 35.49
(0.31%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 1.65 Billion CNY | -11.49% |
| 2022 | 1.85 Billion CNY | 9.95% |
| 2021 | 1.68 Billion CNY | 10.87% |
| 2020 | 1.52 Billion CNY | -41.89% |
| 2019 | 2.61 Billion CNY | 30.03% |
| 2018 | 2.01 Billion CNY | 17.78% |
| 2017 | 1.71 Billion CNY | 33.71% |
| 2016 | 1.27 Billion CNY | 15.61% |
| 2015 | 1.1 Billion CNY | 17.26% |
| 2014 | 943.7 Million CNY | 16.62% |
| 2013 | 809.2 Million CNY | 24.97% |
| 2012 | 647.53 Million CNY | 40.28% |
| 2011 | 461.59 Million CNY | 33.91% |
| 2010 | 344.7 Million CNY | 54.57% |
| 2009 | 223.01 Million CNY | 57.37% |
| 2008 | 141.7 Million CNY | 63.66% |
| 2007 | 86.58 Million CNY | 50.1% |
| 2006 | 57.68 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 530.29 Million CNY | 3.16% |
| 2024 Q2 | 513.88 Million CNY | -7.47% |
| 2024 Q1 | 555.37 Million CNY | 9.53% |
| 2023 Q4 | 507.03 Million CNY | 43.27% |
| 2023 Q2 | 394.33 Million CNY | -2.97% |
| 2023 Q1 | 406.39 Million CNY | -10.31% |
| 2023 Q3 | 353.89 Million CNY | -10.26% |
| 2023 FY | 1.64 Billion CNY | -11.49% |
| 2022 Q1 | 484.93 Million CNY | -15.9% |
| 2022 Q4 | 453.12 Million CNY | 1.5% |
| 2022 Q3 | 446.43 Million CNY | -5.3% |
| 2022 FY | 1.85 Billion CNY | 9.95% |
| 2022 Q2 | 471.41 Million CNY | -2.79% |
| 2021 Q2 | 336.94 Million CNY | -3.81% |
| 2021 Q1 | 350.29 Million CNY | -6.31% |
| 2021 Q3 | 424.12 Million CNY | 25.88% |
| 2021 Q4 | 576.6 Million CNY | 35.95% |
| 2021 FY | 1.68 Billion CNY | 10.87% |
| 2020 Q3 | 337.82 Million CNY | -3.67% |
| 2020 Q4 | 373.89 Million CNY | 10.68% |
| 2020 FY | 1.52 Billion CNY | -41.89% |
| 2020 Q1 | 460.08 Million CNY | -30.27% |
| 2020 Q2 | 350.69 Million CNY | -23.78% |
| 2019 Q2 | 566.52 Million CNY | 1.08% |
| 2019 FY | 2.61 Billion CNY | 30.03% |
| 2019 Q1 | 560.48 Million CNY | 13.16% |
| 2019 Q3 | 833.15 Million CNY | 47.06% |
| 2019 Q4 | 659.75 Million CNY | -20.81% |
| 2018 Q2 | 469.22 Million CNY | 9.32% |
| 2018 Q4 | 495.28 Million CNY | -20.26% |
| 2018 FY | 2.01 Billion CNY | 17.78% |
| 2018 Q1 | 429.2 Million CNY | -8.41% |
| 2018 Q3 | 621.16 Million CNY | 32.38% |
| 2017 Q3 | 454.18 Million CNY | 1.83% |
| 2017 Q2 | 446.01 Million CNY | 30.45% |
| 2017 FY | 1.71 Billion CNY | 33.71% |
| 2017 Q1 | 341.9 Million CNY | -8.4% |
| 2017 Q4 | 468.59 Million CNY | 3.17% |
| 2016 Q2 | 318.07 Million CNY | 10.49% |
| 2016 FY | 1.27 Billion CNY | 15.61% |
| 2016 Q4 | 373.25 Million CNY | 24.35% |
| 2016 Q1 | 287.88 Million CNY | -0.43% |
| 2016 Q3 | 300.17 Million CNY | -5.63% |
| 2015 Q2 | 266.13 Million CNY | 9.78% |
| 2015 FY | 1.1 Billion CNY | 17.26% |
| 2015 Q4 | 289.13 Million CNY | -6.41% |
| 2015 Q3 | 308.93 Million CNY | 16.08% |
| 2015 Q1 | 242.42 Million CNY | -10.31% |
| 2014 FY | 943.7 Million CNY | 16.62% |
| 2014 Q4 | 270.29 Million CNY | 15.37% |
| 2014 Q1 | 214.11 Million CNY | -7.28% |
| 2014 Q3 | 234.27 Million CNY | 4.12% |
| 2014 Q2 | 225.01 Million CNY | 5.09% |
| 2013 Q2 | 195.7 Million CNY | 12.25% |
| 2013 FY | 809.2 Million CNY | 24.97% |
| 2013 Q4 | 230.92 Million CNY | 10.9% |
| 2013 Q3 | 208.22 Million CNY | 6.4% |
| 2013 Q1 | 174.34 Million CNY | -7.26% |
| 2012 Q1 | 132.72 Million CNY | -0.92% |
| 2012 FY | 647.53 Million CNY | 40.28% |
| 2012 Q2 | 162.6 Million CNY | 22.52% |
| 2012 Q3 | 164.21 Million CNY | 0.99% |
| 2012 Q4 | 187.99 Million CNY | 14.48% |
| 2011 Q2 | 111.83 Million CNY | 25.67% |
| 2011 Q1 | 88.99 Million CNY | -13.37% |
| 2011 FY | 461.59 Million CNY | 33.91% |
| 2011 Q4 | 133.96 Million CNY | 5.65% |
| 2011 Q3 | 126.8 Million CNY | 13.38% |
| 2010 Q1 | 68.41 Million CNY | -14.07% |
| 2010 Q2 | 85.82 Million CNY | 25.45% |
| 2010 Q3 | 87.74 Million CNY | 2.23% |
| 2010 Q4 | 102.72 Million CNY | 17.08% |
| 2010 FY | 344.7 Million CNY | 54.57% |
| 2009 Q1 | 42.71 Million CNY | -12.5% |
| 2009 Q2 | 49.6 Million CNY | 16.14% |
| 2009 Q3 | 51.08 Million CNY | 2.98% |
| 2009 FY | 223.01 Million CNY | 57.37% |
| 2009 Q4 | 79.61 Million CNY | 55.86% |
| 2008 Q3 | 28.71 Million CNY | 0.0% |
| 2008 FY | 141.7 Million CNY | 63.66% |
| 2008 Q4 | 48.81 Million CNY | 70.0% |
| 2007 FY | 86.58 Million CNY | 50.1% |
| 2006 FY | 57.68 Million CNY | 0.0% |